Novacyt S.A (ALNOV) | Stock Overview & Key Data

What is ALNOV's 52-week high and low?

In the last 52 weeks, Novacyt S.A reached a high of €1.59 (on August 19, 2024) and a low of €0.42 (on April 7, 2025).

What is the market cap and P/E ratio for ALNOV?

Curious about Novacyt S.A's size and valuation? Its market capitalization stands at 34.88M. When it comes to valuation, the P/E ratio (trailing twelve months) is -0.82, and the forward P/E (looking ahead) is 1.88.

Does ALNOV pay dividends? If so, what's the yield?

As for dividends, Novacyt S.A isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Novacyt S.A's main competitors or similar companies to consider before investing?

When looking at Novacyt S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Eurobio Scientific ALERS	253.37M	Healthcare	Medical Devices	82.97%	11.92%
Affluent Medical AFME	53.31M	Healthcare	Medical Devices	-13.38%	-60.00%
Carmat S.A ALCAR	24.77M	Healthcare	Medical Devices	-76.25%	-94.75%
Median Technologies ALMDT	25.56M	Healthcare	Medical Devices	-11.85%	-78.67%
Diagnostic Medical ALDMS	24.24M	Healthcare	Medical Devices	43.48%	7.32%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Novacyt S.A.? (e.g., ROE, Debt/Equity)

To get a sense of Novacyt S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -57.28%, the Debt to Equity ratio from the most recent quarter is 24.81, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for ALNOV?

Looking at Novacyt S.A's growth, its revenue over the trailing twelve months (TTM) was €23M. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.

How much of ALNOV stock is held by insiders and institutions?

Wondering who owns Novacyt S.A stock? Company insiders (like executives and directors) hold about 0.22% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.

For more common questions about our data, please visit our About Data page.